Vihann Kong
Direttore/Membro del Consiglio presso Applied BioMath LLC
Provenienza dei contatti di primo grado di Vihann Kong
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Applied BioMath LLC
 Applied BioMath LLC Packaged SoftwareTechnology Services Applied BioMath LLC operates as a biotechnology company. The firm uses mathematical modeling and simulation to provide quantitative and predictive guidance to biotechnology and pharmaceutical companies to help accelerate and de-risk drug research and development. It specializes in mechanistic PK/PD, quantitative decision making, risk assessments, predict optimal drug properties for lead gen or clinical candidate selection, phase 1 and phase 2 support and analysis, technical due diligence. The company was founded by John M. Burke, Joshua Apgar and Andrew Sutherland in 2013 and is headquartered in Concord, MA.
4
| Subsidiary | Packaged Software | 4 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Vihann Kong tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| MERRIMACK PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| University of Massachusetts | College/University | Undergraduate Degree | |
| London School of Economics & Political Science | College/University | Graduate Degree | |
| Trinity College, Cambridge | College/University | Doctorate Degree | |
| Harvard Medical School | College/University | Corporate Officer/Principal | |
| Genuity Corp. | Corporate Officer/Principal | ||
RareCyte, Inc.
 RareCyte, Inc. Medical SpecialtiesHealth Technology RareCyte Inc. develops life science research and diagnostic that focuses on characterizing and isolating rare cells in the blood. It engages in bringing its technology to the life sciences research, drug development and diagnostic markets providing new tools to answer difficult questions related to cancer and cardiovascular disease. It's ground-breaking sccuCyte system is an open platform for the unbiased discovery and isolation of circulating tumor cells and circulating endothelial cells from whole blood. The company was founded by Ronald Seubert in 2009 and is headquartered in Seattle, WA. | Medical Specialties | Director/Board Member | |
Glencoe Software, Inc.
 Glencoe Software, Inc. Miscellaneous Commercial ServicesCommercial Services Glencoe Software, Inc. provides scientific image data solutions. It products include OMERO Plus, Bio-Formats, PathViewer, DataViewer and Data InPress. The firm offers customization, support and data publishing services. The company was founded by Jason Swedlow in 2005 and is headquartered in Seattle, WA. | Miscellaneous Commercial Services | Director/Board Member | |
| Harvard College | College/University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 11 |
| Regno Unito | 2 |
Settori
| Consumer Services | 6 |
| Health Technology | 3 |
| Technology Services | 3 |
| Finance | 2 |
| Commercial Services | 2 |
Posizioni
| Director/Board Member | 7 |
| Director of Finance/CFO | 3 |
| Corporate Officer/Principal | 3 |
| Founder | 3 |
| Chief Administrative Officer | 2 |
Contatti più connessi
| Insiders | |
|---|---|
| Andrew Sutherland | 7 |
| Peter Sorger | 7 |
| John M. Burke | 1 |
| Joshua Apgar | 1 |
- Borsa valori
- Insiders
- Vihann Kong
- Connessioni Società
